Quantitative and functional evaluation of innate immune responses in patients with common variable immunodeficiency

Journal of Investigational Allergology and Clinical Immunology

Volumn 21, Issue 3, 2011, Pages 207-215

  Trujillo, C M ^a   Muskus, C ^a   Arango, J ^a   Patino P J ^a   Montoya, C J ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Common variable immunodefi ciency; CpG oligodeoxynucleotides; Innate immunity; Lipopolysaccharide; Lipoteichoic acid

Indexed keywords

B7 ANTIGEN; CD1D ANTIGEN; CD69 ANTIGEN; CD86 ANTIGEN; GENOMIC DNA; LIPOPOLYSACCHARIDE; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA SEQUENCE; FEMALE; FLOW CYTOMETRY; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE GENE; IMMUNOMODULATION; IMMUNOPHENOTYPING; IMMUNOSTIMULATION; INNATE IMMUNITY; LIGAND BINDING; LYMPHOCYTE COUNT; MALE; NATURAL KILLER T CELL; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIGENS, CD; ANTIGENS, SURFACE; COMMON VARIABLE IMMUNODEFICIENCY; CYTOKINES; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; YOUNG ADULT;

EID: 79955427335     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bayry J, Hermine O, Webster DA, Lévy Y, Kaveri SV. Common variable immunodefi ciency: the immune system in chaos. Trends Mol Med. 2005; 11: 370-6.
2. Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Dräger R et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodefi ciency. Nat Immunol. 2003; 4: 261-8.
3. Salzer U, Chapel HM, Webster AD, Pan-Hammarström Q, Schmitt-Graeff A, Schlesier M et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet. 2005; 37: 820-8.
4. van Zelm MC, Reisli I, van der Burg M, Castaño D, van Noesel CJ, van Tol MJ et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med. 2006; 354: 1901-2.
5. Van Zelm MC, Smet J, Adams B, Mascart F, Schandené L, Janssen F et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody defi ciency, J Clin Invest. 2010; 120: 1265-74.
6. Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Galicier L, Lepelletier Y, Webster D et al. Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood. 2004; 104: 2441-3.
7. Scott-Taylor TH, Green MR, Eren E, Webster AD. Monocyte derived dendritic cells responses in common variable immunodefi ciency. Clin Exp Immunol. 2004; 138: 484-90.
8. Viallard JF, Camou F, André M, Liferman F, Moreau JF, Pellegrin JL et al. Altered dendritic cell distribution on patients with common variable immunodefi ciency. Arthritis Res Ther. 2005; 7: R1052-5.
9. Cunningham-Rundles C, Radigan L. Defi cient IL-12 and dendritic cell function in common variable immunodefi ciency. Clin Immunol. 2005; 115: 147-53.
10. Martinez-Pomar N, Raga S, Ferrer J, Pons J, Munoz-Saa I, Julia MR et al. Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analisis of IL-12p40 and interferon-gamma gene. Clin Exp Immunol. 2006; 144: 233-8.
11. Scott-Taylor TH, Green MR, Raeiszadeh M, Workman S, Webster AD. Defective maturation of dendritic cells in common variable immunodefi ciency. Clin Exp Immunol. 2006;145: 420-7.
12. R. Cambronero, Sewell WA, North ME, Webster AD, Farrant J. Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodefi ciency. J Immunol. 2000; 164: 488-94.
13. Aspalter RM, Sewell WA, Dolman K, Farrant J, Webster AD. Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia. Clin Exp Immunol. 2000; 121: 506-14.
14. Cunningham-Rundles C, Radigan L, Knight AK, Zhang L, Bauer L, Nakazawa A. TLR9 activation is defective in common variable immunodefi ciency. J Immunol. 2006; 176: 1978-87.
15. Schröder NW, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis. 2005; 5: 156-64.
16. von Aulock S, Schröder NW, Traub S, Gueinzius K, Lorenz E, Hartung T et al. Heterozygous toll-like receptor 2 polymorphism does not affect lipoteichoic acid-induced chemokine and infl ammatory responses. Infect Immun. 2004; 72: 1828-31.
17. Bochud P, Hawn TR, Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signalling. J Immunol. 2003; 170: 3451-4.
18. Lazarus R, Klimecki WT, Raby BA, Vercelli D, Palmer LJ, Kwiatkowski DJ et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics. 2003; 81: 85-91.
19. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodefi ciencies. Clin Immunol. 1999; 93: 190-7.
20. Commans-Bitter WM, de Groot R, van den Beernd R, Neijens HJ, Hop WC, Groeneveld K et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocytes subpopulations. J Pediatr. 1997; 130: 388-93.
21. Warnatz K, Denz A, Dräger R, Braun M, Groth C, Wolff-Vorbeck G et al. Severe deficiency of switched memory B cells (CD27+IgM-IgD-) in subgroups of patients with common variable immunodefi ciency: a new approach to classify a heterogeneous disease. Blood. 2002; 99: 1544-51.
22. Piqueras B, Lavenu-Bombled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, Chevret S et al. Common variable immunodeficiency patient classifi cation based on impared B cell memory differentiation correlates with clinical aspects. J Clin Immunol. 2003; 23: 385-400.
23. Lauzon NM, Mian F, MacKenzie R, Ashkar AA. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cel Immunol. 2006; 241: 102-12.
24. Galli G, Pittoni P, Tonti E, Malzone C, Uematsu Y, Tortoli M et al. Invariant NKT cells sustain specifi c B cell responses and memory. Proc Natl Acad Sci USA 2007; 104: 3984-9.
25. Fulcher DA, Avery DT, Fewings NL, Berglund LJ, Wong S, Riminton DS et al. Invariant natural killer (iNK) T cell deficiency in patients with common variable immunodefi ciency. Clin Exp Immunol. 2009; 157: 365-9.
26. Van der Vliet HJ, von Blomberg BM, Nishi N, Reijim M, Voskuyl AE, van Bodegraven AA et al. Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol. 2001; 100: 144-8.
27. Montoya CJ, Jie HB, Al-Harthi L, Mulder C, Patiño PJ, Rugeles MT et al. Activation of plasmocytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cells. J Immunol. 2006; 177: 1028-39.
28. Moser C, Schlesier M, Dräger R, Eibel H, Peter HH. Transient CD80 expression defect in a patient with variable immunodeficiency and cyclic neutropenia. Int Arch Allergy Immunol. 1997; 112: 96-9.